Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Half year ended on September 30, 2026.

Date: 27.10.2026 Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524748 Dear Sir/Madam, Sub: Intimation of Board Meeting for approval of Unaudited Financial Results for the quarter and half year ended September 30, 2026 & Closure of Trading Window This is to inform that pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 03th November, 2026, inter-alia to consider and approve the unaudited financial results of the Company for the quarter and half year ended on September 30, 2026. Further, in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the trading window of the Company is already closed from 01st October, 2026 and will open 48 hours after the declaration of unaudited financial results for the quarter and half year ended 30th September, 2026, intimation of which has already been provided to BSE as on September 26, 2026. Kindly take the same on record. Thanking you, Yours faithfully, For Link Pharma Chem Limited Komal Bhojwani Company Secretary & Compliance Officer Membership No.: A65594 REGISTERED OFFICE: Plot No. 162, G.I.D.C., Nandesari - 391340, Dist. Vadodara (Gujarat) (India) Tel. (O) 9925057946 E-Mail: linkpharmacs@gmail.com CIN: L24230GJ1984PLC007540 Website: www.linkpharmachem.co.in